$Takeda Pharmaceutical (TAK.US)$ COMMERCIAL AVAILABILITY OF LIVTENCITY!! first and only treatment for the disease
$Biofrontera (BFRI.US)$  $CooTek (CTK.US)$

Maribavir will be the first and only treatment indicated for adults in this patient population, expected net profit value at amazing $1.118B
$Takeda Pharmaceutical (TAK.US)$ 
CMV is a beta herpes virus that commonly affects individuals who have compromised immune systems. Out of the approximately 200,000 adult transplants per year worldwide, CMV is one of the most common viral infections. It has an estimated incidence rate of between 16% and 56% in solid organ transplant recipients and 30% to 70% percent in hematopoietic stem cell transplant patients. 
$Pasithea Therapeutics (KTTA.US)$ 
$Petros Pharmaceuticals (PTPI.US)$ 
$iSpecimen (ISPC.US)$ 
$Longeveron (LGVN.US)$

$Sono Group (SEV.US)$
Only 1m float of stock available, HODL for high price Sion A spacious electric car with a range of up to 305 kilometers that charges itself through the power of the sun.
Takes 30mins to charge vehicle to 80% and the rest could just charge on the go with solar power!
Sono reported more than 14,000 reservations with advance payments, resulting in total net cash inflows of 38.8 million euros ($45.16 million) from its customers by August-end, up from total net cash inflows of 37.9 million euros at the end of June. These reservations correspond to a net sales volume of about 300 million euros.
It plans to license and sell its solar technology to manufacturers of buses, trucks, camper vans, trains and even boats, Sono said. https://sonomotors.com/en/solar-integration/
In addition, their Cybertruck has more than 1 million preorders, according to a report from Electrek
Learn more about Sonomotors in their video https://www.youtube.com/watch?v=9MlQMG5S-_o
$Sono Group (SEV.US)$  $iSpecimen (ISPC.US)$ 
$Tesla (TSLA.US)$
$Pioneer Power Solutions (PPSI.US)$ 
$ChargePoint (CHPT.US)$ 
$Rivian Automotive (RIVN.US)$ 
$Lucid Group (LCID.US)$ 
$Canoo (GOEV.US)$ 
$Gores Guggenheim (GGPI.US)$ 
$Qualigen Therapeutics (QLGN.US)$ 
$Longeveron (LGVN.US)$ 
$Petros Pharmaceuticals (PTPI.US)$ 
$Aadi Biosciences (AADI.US)$ 
$iSpecimen (ISPC.US)$ 
$RLX Technology (RLX.US)$ 
$XPeng (XPEV.US)$ 

$Takeda Pharmaceutical (TAK.US)$
If approved by the FDA, maribavir will be the first and only treatment indicated for adults in this patient population
The FDA has placed Takeda's New Drug Application for maribavir under Priority Review, and this vote of confidence from the AMDAC will be taken into account when the regulator makes its final decision. The NDA submission is based on the Phase III study. The AMDAC also collected insights and responses from advocates, patients, and healthcare providers in a public forum. 
The U.S. Food and Drug Administration's Antimicrobial Drugs Advisory Committee (AMDAC) has unanimously voted on the use of Takeda Pharmaceutical Company's maribavir to treat different types of refractory cytomegalovirus (CMV) infection.
CMV is a beta herpes virus that commonly affects individuals who have compromised immune systems. Out of the approximately 200,000 adult transplants per year worldwide, CMV is one of the most common viral infections. It has an estimated incidence rate of between 16% and 56% in solid organ transplant recipients and 30% to 70% percent in hematopoietic stem cell transplant patients. 
https://www.biospace.com/article/candidate-cmv-infection-therapy-maribavir-gets-nod-from-key-fda-advisory-committee/
https://www.businesswire.com/news/home/20211007006064/en/FDA-Advisory-Committee-Recommends-Use-of-Investigational-Drug-Maribavir-TAK-620-to-Treat-Post-Transplant-Recipients-with-Cytomegalovirus-CMV-Infection-and-Disease-Refractory-to-Treatment-With-or-Without-Resistance
In addition, there was a big insider buy
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) announced that its Board of Directors resolved today to engage in the acquisition of its own shares pursuant to the provision of its Articles of Incorporation in accordance with Article 459, paragraph 1 of the Companies Act of Japan, as detailed below.
“At our current share price, we see an opportunity to buy back our shares at a substantial discount to what we perceive is their underlying value,” said Costa Saroukos, director and Chief Financial Officer of Takeda. “We expect that this share buyback of up to 100B yen will not impact our deleveraging plans, and that we will remain firmly on track to deliver on our target for 2x (‘low twos’) net debt to Adjusted EBITDA by the end of FY23. We are also maintaining our existing dividend policy and updating our capital allocation policy to allow for share buybacks in the future when appropriate. This underscores our business’ strong cash generation ability, our confidence in our fundamental growth driven by the 14 global brands, and our belief that the R&D strategy with ~40 new molecular entities in the pipeline, will deliver for the long term.”
This buyback of shares will be funded by Takeda’s operating cash flow driven by growth in our 14 global brands and working capital improvements.
https://www.takeda.com/newsroom/newsreleases/2021/takeda-announces-acquisition-of-own-shares/
$Longeveron (LGVN.US)$ 
$RenovoRx (RNXT.US)$ 
$Novavax (NVAX.US)$ 
$ChemoCentryx (CCXI.US)$ 
$Pfizer (PFE.US)$ 
$Futu Holdings Ltd (FUTU.US)$ 
$Moderna (MRNA.US)$ 
$BioNTech (BNTX.US)$ 
$CorMedix (CRMD.US)$ 
$Amgen (AMGN.US)$ 
$Sanofi (SNY.US)$ 
$Bristol-Myers Squibb (BMY.US)$ 
$MERCK KGAA SPON ADR EACH REPR 0.2 ORD SHS (MKKGY.US)$ 
$Johnson & Johnson (JNJ.US)$ 
$AbbVie (ABBV.US)$ 
$Novartis AG (NVS.US)$ 
$ROCHE HOLDING AG (RHHBY.US)$ 
$iSpecimen (ISPC.US)$ 
$Petros Pharmaceuticals (PTPI.US)$ 
$Aadi Biosciences (AADI.US)$ 
$Pasithea Therapeutics (KTTA.US)$ 
$Fennec Pharmaceuticals (FENC.US)$ 

$Sono Group (SEV.US)$
Only 10m float of stock available, HODL for high price. Combination of EV and solar panel in one. Market cap is way lower as compared to competitors
Sion
A spacious electric car with a range of up to 305 kilometers that charges itself through the power of the sun.
Takes 30mins to charge vehicle to 80% and the rest could just charge on the go with solar power!
Sono reported more than 14,000 reservations with advance payments, resulting in total net cash inflows of 38.8 million euros ($45.16 million) from its customers by August-end, up from total net cash inflows of 37.9 million euros at the end of June. These reservations correspond to a net sales volume of about 300 million euros.
It plans to license and sell its solar technology to manufacturers of buses, trucks, camper vans, trains and even boats, Sono said. https://sonomotors.com/en/solar-integration/
In addition, their Cybertruck has more than 1 million preorders, according to a report from Electrek
Learn more about Sonomotors in their video https://www.youtube.com/watch?v=9MlQMG5S-_o
$Sono Group (SEV.US)$ 
$Pioneer Power Solutions (PPSI.US)$ 
$Longeveron (LGVN.US)$ 
$Phunware (PHUN.US)$ 
$Alibaba (BABA.US)$  
$Rivian Automotive (RIVN.US)$ 
$Tesla (TSLA.US)$  
$Lucid Group (LCID.US)$  
$Canoo (GOEV.US)$ 
$Gores Guggenheim (GGPI.US)$ 
$Futu Holdings Ltd (FUTU.US)$ 
$Apple (AAPL.US)$ 
$Biora Therapeutics (PROG.US)$  
$NVIDIA (NVDA.US)$ 

$Sono Group (SEV.US)$
As of November 5, 2021, the company had over 16,000 reservations for future deliveries totaling approximately $43.9 million in deposits received.
https://sonomotors.com

$Cenntro Electric (NAKD.US)$
11/08/2021 (MT Newswires) -- Naked Brand Group (NAKD) and Cenntro Automotive Group, Inc. said Monday that they have entered into a definitive agreement under which Naked will acquire the outstanding stock in three entities comprising Cenntro Automotive Group in a stock for stock acquisition agreement According to a media release, Cenntro is a commercial EV technology company with advanced market-validated commercial vehicles and autonomous driving technologies.Upon completion of the transaction, the company expects to change its name to Cenntro Automotive Group and retain its Nasdaq listing and ticker symbol "NAKD".The transaction is expected to close by the year-end of 2021.
$Rivian Automotive (RIVN.US)$ 
$RenovoRx (RNXT.US)$ 
$Tesla (TSLA.US)$ 
$NIO Inc (NIO.US)$ 
$Lucid Group (LCID.US)$ 
$EVgo Inc (EVGO.US)$ 
$Pioneer Power Solutions (PPSI.US)$

$NRX Pharmaceuticals (NRXP.US)$ there are not enough data provided by NRX but NRX is gonna update FDA with more trial results soon! what a cheap price to buy in😆

Come to $Farmmi (FAMI.US)$ $Digital Brands Group (DBGI.US)$ When the daily trading volume increases to at least double the average, while the price of the penny stock moves higher, it can be an excellent time to invest. This is often the beginning of a nice upward price trend.

$Digital World Acquisition Corp (DWAC.US)$
$Digital World Acquisition Corp(DWAC.US)$ Digital World Acquisition Corp Chief Executive Patrick Orlando said that a regulatory filing providing more details on his deal to take former U.S. President Donald Trump's new social media venture public will be published "soon". "Maybe around Thursday," Orlando said when reached by Reuters by phone and asked when he would be releasing more financial details about the deal. https://twitter.com/thehoffather/status/1453527229967724548?s=21 https://www.todayonline.com/world/digital-world-ceo-says-more-trump-deal-details-coming https://www.thenewzealandtimes.com/digital-world-ceo-says-more-details-on-trump-deal-to-come/?amp $Phunware Inc(PHUN.US)$  $Remark Holdings Inc(MARK.US)$  $Futu Holdings Limited(FUTU.US)$  $Tesla(TSLA.US)$